Earnings Preview: LAKE to Report Financial Results Post-market on December 05
Trump Nominates Marty Makary For FDA Commissioner
The "Diet Duo" leads a sharp decline in pharmaceutical stocks, as Trump's new health secretary opposes vaccines and weight loss drugs.
Kennedy, known as the "anti-vaccine pioneer," strongly opposes GLP-1 drugs, believing they are the wrong approach to addressing the obesity crisis. On Friday, the stock prices of the "weight loss giants" eli lilly and co and novo-nordisk a/s fell by 4.93% and 3.4%, respectively, and other companies dedicated to developing weight loss drugs also suffered heavy losses.
US Manufacturing Index Rises To 43, Highest Since 2020
Sell-off of US vaccine stocks intensifies! Analyst: Little Kennedy brings uncertainty to the entire industry.
1. On Friday Eastern Time, vaccine manufacturers' stocks plummeted as Donald Trump selected vaccine skeptic Kennedy as Health Secretary, causing industry uncertainty. Moderna, Novavax, Pfizer, and other stock prices were all affected. 2. Analysts pointed out that Kennedy's anti-vaccine stance may weaken public trust in vaccines, leading to a decrease in the vaccination rate in the USA, increasing the risk of outbreaks of diseases such as measles and whooping cough.
Vaccines stocks in the usa collectively plummet! Trump surprisingly appoints an anti-vaccine advocate as the Secretary of Health in the usa.
① Trump nominated Robert F. Kennedy Jr. as the new Secretary of Health and Human Services, which triggered a sell-off in vaccine companies; ② Kennedy advocates very radical views, opposing vaccines since 2005, and questioning the transparency of the usa government in public health information.
Lakeland Industries To Go Ex-Dividend On November 15th, 2024 With 0.03 USD Dividend Per Share
Express News | Lakeland Industries Inc: Provided Notice to CFO Roger Shannon of Non-Renewal of Employment Agreement
Express News | Lakeland Industries Inc: An's Employment With Company Will Continue on at Will Basis
Express News | Lakeland Industries Inc: On Oct 31, Terminates COO Hui (Helena) An's Employment Agreement
Lakeland Industries Adjusts Executive Employment Strategy
Lakeland Declares $0.03 Dividend
Lakeland Industries Management to Meet With Roth MKM
Lakeland Industries Engages MZ Group for Investor Relations Program
Chuck Royce's Strategic Acquisition in Lakeland Industries
Are Lakeland Industries, Inc.'s (NASDAQ:LAKE) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?
Maxim Group Maintains Lakeland Industries(LAKE.US) With Buy Rating, Announces Target Price $27
Lakeland Industries | 10-Q: Q2 2025 Earnings Report
Q2 2025 Lakeland Industries Inc Earnings Call
Lakeland Industries, Inc. (LAKE) Q2 2025 Earnings Call Transcript Summary